Tauopathies are a class of neurodegenerative diseases, including Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy, which are associated with the pathological aggregation of tau protein into neurofibrillary tangles (NFT). Studies have characterized tau as a "prion-like" protein given its ability to form distinct, stable amyloid conformations capable of transcellular and multigenerational propagation in clonal fashion. It has been proposed that progression of tauopathy could be due to the prion-like propagation of tau, suggesting the possibility that end-stage pathologies, like NFT formation, may require an instigating event such as tau seeding. To investigate this, we applied a novel human induced pluripotent stem cell (hiPSC) system we have developed to serve as a human neuronal model. We introduced the tau repeat domain (tau-RD) with P301L and V337M (tau-RD-LM) mutations into hiPSC-derived neurons and observed expression of tau-RD at levels similar to total tau in postmortem AD brains. Tau aggregation occurred without the addition of recombinant tau fibrils. The conditioned media from tau-RD cultures contained tau-RD seeds, which were capable of inducing aggregate formation in homotypic mode in non-transduced recipient neuronal cultures. The resultant NFTs were thioflavinpositive, silver stain-positive, and assumed fibrillary appearance on transmission electron microscopy (TEM) with immunogold, which revealed paired helical filament 1 (PHF1)-positive NFTs, representing possible recruitment of endogenous tau in the aggregates. Functionally, expression of tau-RD caused neurotoxicity that manifested as axon retraction, synaptic density reduction, and enlargement of lysosomes. The results of our hiPSC study were reinforced by the observation that Tau-RD-LM is excreted in exosomes, which mediated the transfer of human tau to wild-type mouse neurons in vivo. Our hiPSC human neuronal system provides a model for further studies of tau aggregation and pathology as well as a means to study transcellular propagation and related neurodegenerative mechanisms.
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Introduction
Tau pathology is characterized by the presence of abnormally hyperphosphorylated tau protein that has misfolded into insoluble aggregates known as neurofibrillary tangles (NFT). Tau protein is abundant in neurons, acting to stabilize microtubules and facilitate axonal transport. When hyperphosphorylated, tau has a heightened tendency to misfold, losing its ability to interact with microtubules (Iqbal et al., 2009 ). An accumulation of pathologically aggregated tau protein is often observed in postmortem brains from patients suffering from tauopathies. In Alzheimer's disease (AD), there is build-up of both amyloid plaques and neurofibrillary tangles, with the appearance of NFTs Abbreviations: AD, Alzheimer's disease; NFT, neurofibrillary tangles; hiPSC, human induced pluripotent stem cell; PHF, paired helical filament; FTD, frontotemporal dementia; NDC, non-demented control; PS-1, presenilin 1; YFP, yellow fluorescent protein.
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